This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Wertz DA, Chang C-L, Sarawate CA, Willey VJ, Cziraky MJ, Bohn RL.Risk of cardiovascular events and all-cause mortality in patients treated with thiazolidinediones in a managed-care population. Circulation: Cardiovascular Quality and Outcomes 3: 538-545, 24 Aug 2010. Available from: URL: http://dx.doi.org/10.1161/CIRCOUTCOMES.109.911461
Rights and permissions
About this article
Cite this article
Similar CV risks observed with rosiglitazone and pioglitazone. React. Wkly. 1318, 5 (2010). https://doi.org/10.2165/00128415-201013180-00009
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013180-00009